126 related articles for article (PubMed ID: 3178380)
1. Pleuropulmonary disease during bromocriptine treatment of Parkinson's disease.
McElvaney NG; Wilcox PG; Churg A; Fleetham JA
Arch Intern Med; 1988 Oct; 148(10):2231-6. PubMed ID: 3178380
[TBL] [Abstract][Full Text] [Related]
2. Pleuropulmonary disease associated with dopamine agonist therapy.
Bhatt MH; Keenan SP; Fleetham JA; Calne DB
Ann Neurol; 1991 Oct; 30(4):613-6. PubMed ID: 1686385
[TBL] [Abstract][Full Text] [Related]
3. Pleuropulmonary changes during treatment of Parkinson's disease with a long-acting ergot derivative, cabergoline.
Frans E; Dom R; Demedts M
Eur Respir J; 1992 Feb; 5(2):263-5. PubMed ID: 1348483
[TBL] [Abstract][Full Text] [Related]
4. Pleuropulmonary involvement during bromocriptine treatment.
Kinnunen E; Viljanen A
Chest; 1988 Nov; 94(5):1034-6. PubMed ID: 3180854
[TBL] [Abstract][Full Text] [Related]
5. Pleural disease during treatment with bromocriptine in patients previously exposed to asbestos.
Hillerdal G; Lee J; Blomkvist A; Rask-Andersen A; Uddenfeldt M; Koyi H; Rasmussen E
Eur Respir J; 1997 Dec; 10(12):2711-5. PubMed ID: 9493648
[TBL] [Abstract][Full Text] [Related]
6. [Bromocriptine in Parkinson's disease: pleuropulmonary toxicity].
Douvier JJ; Vergeret J; Taytard A; Brottier E; Domblides P; Dubos F; Freour P
Ann Med Interne (Paris); 1985; 136(5):416-8. PubMed ID: 4062141
[TBL] [Abstract][Full Text] [Related]
7. Constrictive pericarditis and pleuropulmonary disease linked to ergot dopamine agonist therapy (cabergoline) for Parkinson's disease.
Ling LH; Ahlskog JE; Munger TM; Limper AH; Oh JK
Mayo Clin Proc; 1999 Apr; 74(4):371-5. PubMed ID: 10221467
[TBL] [Abstract][Full Text] [Related]
8. [Bromocriptine-induced pleuropneumopathy].
Schmid PA; Suter T; Speich R; Eberli F; Greminger P
Dtsch Med Wochenschr; 1994 Nov; 119(45):1543-6. PubMed ID: 7956789
[TBL] [Abstract][Full Text] [Related]
9. [Diffuse interstitial lung disease without pleural involvement and high-dose bromocriptine].
Marsaudon E; Castet D; Barrault MF; Allais C
Rev Mal Respir; 1997 Nov; 14(5):405-7. PubMed ID: 9480488
[TBL] [Abstract][Full Text] [Related]
10. Pleuropulmonary changes induced by ergoline drugs.
Pfitzenmeyer P; Foucher P; Dennewald G; Chevalon B; Debieuvre D; Bensa P; Piard F; Camus P
Eur Respir J; 1996 May; 9(5):1013-9. PubMed ID: 8793465
[TBL] [Abstract][Full Text] [Related]
11. Pleuropulmonary disease as a side-effect of treatment with bromocriptine.
Comet R; Domingo C; Such JJ; Ribera G; Sans J; Marín A
Respir Med; 1998 Sep; 92(9):1172-4. PubMed ID: 9926176
[No Abstract] [Full Text] [Related]
12. [Pleuropneumopathy caused by bromocriptine in a patient with Parkinson disease. Review of the literature apropos of a new case].
Debove P; Simon F; Vaylet F; Renard JL; L'Her P
Ann Med Interne (Paris); 1998 Apr; 149(3):167-71. PubMed ID: 11490541
[TBL] [Abstract][Full Text] [Related]
13. [Pleuro-pulmonary changes after bromocriptine treatment of parkinsonism].
Bøttcher J; Grøn U
Ugeskr Laeger; 1981 Oct; 143(41):2648-9. PubMed ID: 7303288
[No Abstract] [Full Text] [Related]
14. Pleuropulmonary fibrosis due to bromocriptine treatment for Parkinson's disease.
Todman DH; Oliver WA; Edwards RL
Clin Exp Neurol; 1990; 27():79-82. PubMed ID: 2129961
[TBL] [Abstract][Full Text] [Related]
15. Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson Disease.
Tintner R; Manian P; Gauthier P; Jankovic J
Arch Neurol; 2005 Aug; 62(8):1290-5. PubMed ID: 16087771
[TBL] [Abstract][Full Text] [Related]
16. [Pleural effusion and severe edema of the lower limbs induced by bromocriptine].
Messiaen T; Lefebvre C; Weynand B; Pieters T
Rev Med Interne; 1996; 17(8):680-3. PubMed ID: 8881198
[TBL] [Abstract][Full Text] [Related]
17. Pleuropulmonary reactions in patients on bromocriptine treatment.
Tornling G; Unge G; Axelsson G; Noring L; Granerus AK
Eur J Respir Dis; 1986 Jan; 68(1):35-8. PubMed ID: 3948932
[TBL] [Abstract][Full Text] [Related]
18. Bromocriptine induced pleuropulmonary fibrosis.
Wiggins J; Skinner C
Thorax; 1986 Apr; 41(4):328-30. PubMed ID: 3738853
[No Abstract] [Full Text] [Related]
19. Parkinson's disease: a comparison of mesulergine and bromocriptine.
Burton K; Larsen TA; Robinson RG; Bratty PJ; Martin WR; Schulzer M; Calne DB
Neurology; 1985 Aug; 35(8):1205-8. PubMed ID: 3895033
[TBL] [Abstract][Full Text] [Related]
20. Suggestive evidence for bromocriptine-induced pleurisy.
Klaassen RJ; Troost RJ; Verhoeven GT; Krepel HP; van der Lely AJ
Neth J Med; 1996 Jun; 48(6):232-6. PubMed ID: 8710045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
